Dabigatran etexilate
![Dabigatran etexilate Structure](CAS2/GIF/211915-06-9.gif)
- CAS No.
- 211915-06-9
- Chemical Name:
- Dabigatran etexilate
- Synonyms
- DL-;BIBR-1048;N-[[2-[[[4-[[[(Hexyloxy)carbonyl]aMidino]iMinoMethyl]phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridyl-beta-alanine,ethyl ester;Etexilate;Dabigatran ester;BIBR-1048 (Dabigatran);N-[2-[4-[N-(Hexyloxycarbonyl)aMidino]phenylaMinoMethyl]-1-Methyl-1H-benziMidazol-5-ylcarbonyl]-N-(2-;CS-62;Prazaxa;BIBR 1048
- CBNumber:
- CB62485052
- Molecular Formula:
- C34H41N7O5
- Molecular Weight:
- 627.73
- MOL File:
- 211915-06-9.mol
- Modify Date:
- 2023/10/11 9:56:29
Dabigatran etexilate Chemical Properties,Uses,Production
Description
Dabigatran etexilate is an orally administered pro-drug of dabigatran, which is a direct inhibitor of thrombin and a potent anticoagulant. The serine protease thrombin is the final mediator in the coagulation cascade that leads to the production of fibrin, the main protein component of blood clots. Thrombin is also a potent activator of platelets. Consequently, thrombin inhibitors have found utility as anticoagulants in treating arterial and venous thrombosis. Warfarin, although orally available, has a narrow therapeutic index and requires frequent monitoring and dosage adjustment. Low-molecular-weight heparins provide better safety profile and less inter-patient variability; however, these agents are only available for parenteral administration. Direct thrombin inhibitors (DTIs) are a new class of anticoagulants that act by directly binding to thrombin at its catalytic or fibrinogen-binding sites, or both. Unlike the heparins, DTIs do not require the activation of secondary factors such as antithrombin to derive their activity, which makes their action more predictable. In addition, their ability to inhibit both free and clot-bound thrombin predisposes them for enhanced anticoagulation effect.
Uses
Dabigatran Etexilate is an oral anticoagulant and direct thrombin inhibitor.
Definition
ChEBI: An aromatic amide obtained by formal condensation of the carboxy group of 2-{[(4-{N'-[(hexyloxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazole-5-carboxylic acid with the secondary amino group of thyl N-pyridin-2-yl-beta-alaninate. A prodrug for dabigatran, a thrombin inhibitor and anticoagulant which is used for the prevention of stroke and systemic embolism.
Dabigatran etexilate Preparation Products And Raw materials
Raw materials
1of2
chevron_rightPreparation Products
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Jigs Chemical ltd | +919099003427 | Gujarat, India | 239 | 58 | Inquiry |
VASUDHA PHARMA CHEM LIMITED | +91-91-4044763666 +91-9396659284 | Telangana, India | 102 | 58 | Inquiry |
A.R. LIFE SCIENCES PVT. LTD. | +91-914040267679 +91-8519993257 | Hyderabad, India | 100 | 58 | Inquiry |
ANWITA APIS | +919000311012 | Hyderabad, India | 198 | 58 | Inquiry |
KARPSCHEM LABORATORIES | +91-7249203006 +91-7249203006 | Maharashtra, India | 786 | 58 | Inquiry |
Lee Pharma Ltd | +91-9849085929 +91-9849085929 | Hyderabad, India | 42 | 58 | Inquiry |
Nosch Labs Pvt Ltd | +91-4048557474 +91-9948222287 | Hyderabad, India | 58 | 58 | Inquiry |
Afton Pharma | +91-9712000202 +91-9712000202 | Gujarat, India | 63 | 58 | Inquiry |
Chempifine Chemicals | +91-2225667766 +91-2225667766 | Punjab, India | 144 | 58 | Inquiry |
Dr. ASCRO Bio Sciences Private Limited | +undefined-7382260502 +undefined-+91 9182680914 | Telangana, India | 51 | 58 | Inquiry |
Supplier | Advantage |
---|---|
Jigs Chemical ltd | 58 |
VASUDHA PHARMA CHEM LIMITED | 58 |
A.R. LIFE SCIENCES PVT. LTD. | 58 |
ANWITA APIS | 58 |
KARPSCHEM LABORATORIES | 58 |
Lee Pharma Ltd | 58 |
Nosch Labs Pvt Ltd | 58 |
Afton Pharma | 58 |
Chempifine Chemicals | 58 |
Dr. ASCRO Bio Sciences Private Limited | 58 |
Related articles
- Dabigatran Etexilate: A Potent Thrombin Inhibitor for Stroke Prevention in Non-Valvular Atrial Fibrillation
- Dabigatran Etexilate, a prodrug converted to dabigatran, selectively inhibits clot formation. RE-LY trial showed noninferiorit....
- Feb 2,2024
- Dabigatran etexilate: clinical applications and safety
- Dabigatran etexilate offers favorable clinical outcomes and a manageable safety profile for treating and preventing venous thr....
- Oct 11,2023
- Dabigatran etexilate (BIBR-1048)- Pharmacology
- Dabigatran etexilate (Pradaxa, BIBR 1048, Boehringer Ingelheim) is the prodrug of dabigatran (originally known as BIBR 953), a....
- Dec 13,2019
211915-06-9(Dabigatran etexilate)Related Search:
1of4
chevron_right